The North has long warned residents of the dangers of leaflets sent by South Korean activists
Middle East, Southeast Asia and the Americas seeing the biggest increases
Pfizer Inc. and partner BioNTech said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine.
Algorithm uses Google search data plus conventional data, such as case counts, vaccination rates
Advisers to the U.S. government are recommending that COVID-19 booster shots used this fall be modified to better match more recent variants of the coronavirus. A final decision from the Food and Drug Administration is expected within days, and it will have to set the exact recipe for the change.
Health minister says starting July 1 the tests will cost citizens about $3.16 each, with the rest subsidized by the government
Chinese economic hub lifted a two-month city-wide lockdown on June 1, but many establishments have remained unable to offer indoor dining since mid-March
Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection. Saturday's announcement comes days before regulators debate whether to offer Americans updated booster shots this fall. The current COVID-19 vaccines still offer strong protection
Chinese leaders have a record of giving aid and investment to poorer countries to forge relationships that can counter West's global influence
French-Austrian biotech firm has been trying to salvage the deal with the European Commission after its vaccine program was hit by delays in its marketing application due to requests from the EMA for more information
Load more
